Gianluigi Orgera

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. ncbi High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases
    Gianluigi Orgera
    Unit of Interventional Radiology, European Institute of Oncology, 20141, Milan, Italy
    Cardiovasc Intervent Radiol 34:419-23. 2011
  2. ncbi High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results
    G Orgera
    Interventional Radiology Unit of European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Radiol Med 116:734-48. 2011
  3. ncbi High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations
    Franco Orsi
    Interventional Radiology Unit, European Institute of Oncology, 435 Via Ripamonti, 20141 Milan, Italy
    AJR Am J Roentgenol 195:W245-52. 2010
  4. ncbi Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session
    Guido Bonomo
    Unit of Interventional Radiology, European Institute of Oncology, Via Ripamonti 435, 2041, Milan, Italy
    Cardiovasc Intervent Radiol 35:1372-9. 2012
  5. ncbi Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up
    Guido Bonomo
    Unit of Interventional Radiology, European Institute of Oncology, Via Ripamonti 435, 2041 Milan, Italy
    Cardiovasc Intervent Radiol 33:552-9. 2010

Detail Information

Publications5

  1. ncbi High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases
    Gianluigi Orgera
    Unit of Interventional Radiology, European Institute of Oncology, 20141, Milan, Italy
    Cardiovasc Intervent Radiol 34:419-23. 2011
    ..HIFU is likely to be a valid alternative for symptoms control in patients with pancreatic NETs. However, currently the procedure should be reserved for inoperable patients for whom symptoms cannot be controlled by medical therapy...
  2. ncbi High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results
    G Orgera
    Interventional Radiology Unit of European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Radiol Med 116:734-48. 2011
    ..The purpose of this study was to evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for ablation of solid tumours without damaging the surrounding structures...
  3. ncbi High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations
    Franco Orsi
    Interventional Radiology Unit, European Institute of Oncology, 435 Via Ripamonti, 20141 Milan, Italy
    AJR Am J Roentgenol 195:W245-52. 2010
    ..The aim of this study was to evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound therapeutic ablation of solid tumors in difficult locations...
  4. ncbi Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session
    Guido Bonomo
    Unit of Interventional Radiology, European Institute of Oncology, Via Ripamonti 435, 2041, Milan, Italy
    Cardiovasc Intervent Radiol 35:1372-9. 2012
    ....
  5. ncbi Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up
    Guido Bonomo
    Unit of Interventional Radiology, European Institute of Oncology, Via Ripamonti 435, 2041 Milan, Italy
    Cardiovasc Intervent Radiol 33:552-9. 2010
    ..Local results as well as 1-year clinical outcome after TAE with Embozene microspheres are veryly encouraging, however, further studies, a larger patient population, and a longer follow-up are mandatory to assess the real clinical impact...